CLINICAL_TRIALS trial_result · 2017-02-16

Clinical Trial Update: Combined Treatment for Generalized Anxiety Disorder (GAD) [Phase 2]

Phase 2 clinical trial evaluating a combined treatment for generalized anxiety disorder has completed. The results were posted in February 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Pennsylvania | Conditions: Generalized Anxiety Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-02-16